Wedbush Assumes Passage Bio at Outperform, Announces Price Target of $4
Benzinga Newsdesk 1 year ago
NewsPrice TargetInitiationAnalyst Ratings
Wedbush analyst Yun Zhong assumes Passage Bio (NASDAQ:PASG) with a Outperform rating and announces Price Target of $4.
Wedbush analyst Yun Zhong assumes Passage Bio (NASDAQ:PASG) with a Outperform rating and announces Price Target of $4.